• 1
    Blanchard A, Montagnier L, Gougeon ML. Influence of microbial infections on the progression of HIV disease. Trends Microbiol 1997; 5: 32631.
  • 2
    Weisburg WG, Tully JG, Rose DL et al. A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol 1989; 171: 645567.
  • 3
    Lo SC, Dawson MS, Wong DM et al. Identification of Mycoplasma incognitus infection in patients with AIDS. an immunohistochemical, in situ hybridization and ultrastructural study. Am J Trop Med Hyg 1989; 41: 60116.
  • 4
    Lo SC, Hayes MM, Wang RY, Pierce PF, Kotani H, Shih JW. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991; 338: 14158.
  • 5
    Lo SC, Hayes MM, Tully JG, Wang RY, Kotani H, Pierce PF, Rose DL, Shih JW. Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS. Int J Syst Bacteriol 1992; 42: 35764.
  • 6
    Lo SC, Tsai S, Benish JR, Shih JW, Wear DJ, Wong DM. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 1991; 251: 10746.
  • 7
    Lemaitre M, Henin Y, Destouesse F, Ferrieux C, Montagnier L, Blanchard A. Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines. Infect Immun 1992; 60: 7428.
  • 8
    Chowdhury IH, Munakata T, Koyanagi Y, Kobayashi S, Arai S, Yamamoto N. Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. Biochem Biophys Res Commun 1990; 170: 136570.
  • 9
    Chowdhury MI, Munakata T, Koyanagi Y, Arai S, Yamamoto N. Mycoplasma stimulates HIV-1 expression from acutely- and dormantly- infected promonocyte/monoblastoid cell lines. Arch Virol 1994; 139: 4318.
  • 10
    Ou SHI, Gaynor RB. Intracellular factors involved in gene expression of human retroviruses. In: LevyJA, ed. The Retroviridae, Vol. 4. New York: The Plenum Press, 1995: 97.
  • 11
    Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987; 326: 7113.
  • 12
    Skolnik PR, Kosloff BR, Hirsch MS. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 1988; 157: 50814.
  • 13
    Golden MP, Kim S, Hammer SM, Ladd EA, Schaffer PA, DeLuca N, Albrecht MA. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992; 166: 4949.
  • 14
    Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993; 5: 16573.
  • 15
    Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384: 52934.
  • 16
    Wahl SM, Orenstein JM. Immune stimulation and HIV-1 viral replication. J Leukoc Biol 1997; 62: 6771.
  • 17
    Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis 1998; 178: 16428.
  • 18
    Iyama K, Ono S, Kuwano K, Ohishi M, Shigematsu H, Arai S. Induction of tumor necrosis factor alpha (TNF alpha) and enhancement of HIV-1 replication in the J22HL60 cell line by Mycoplasma penetrans. Microbiol Immunol 1996; 40: 90714.
  • 19
    Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 138.
  • 20
    Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285: 7369.
  • 21
    Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 7326.
  • 22
    Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 3341925.
  • 23
    Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 1999; 163: 674855.
  • 24
    Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274: 174069.
  • 25
    Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11: 44351.
  • 26
    Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401: 8115.
  • 27
    Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge. recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 15.
  • 28
    Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Muhlradt PF, Akira S. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164: 5547.
  • 29
    Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 20858.
  • 30
    Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 1068992.
  • 31
    Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 374952.
  • 32
    Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 7405.
  • 33
    Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099103.
  • 34
    Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998; 2: 2538.
  • 35
    Flo TH, Halaas O, Lien E, Ryan L, Teti G, Golenbock DT, Sundan A, Espevik T. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000; 164: 20649.
  • 36
    Nishiguchi M, Matsumoto M, Takao T et al. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J Immunol 2001; 166: 26106.
  • 37
    Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int J Biochem Cell Biol 2002; 34: 9016.
  • 38
    Feng SH, Lo SC. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect Immun 1994; 62: 391621.
  • 39
    Feng SH, Lo SC. Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1. Infect Immun 1999; 67: 29516.
  • 40
    Cann AJ, Koyanagi Y, Chen IS. High efficiency transfection of primary human lymphocytes and studies of gene expression. Oncogene 1988; 3: 1238.
  • 41
    Coffin JM, Rabson AB, Graves BJ. Synthesis and processing of viral RNA. In: CoffinJM, HughesSH, VarmusHE, eds. Retroviruses. New York: Cold Spring Harbor Laboratory Press, 1997: 20561.
  • 42
    Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13: 93340.
  • 43
    Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169: 104.
  • 44
    Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185: 19518.
  • 45
    Kaufmann A, Muhlradt PF, Gemsa D, Sprenger H. Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun 1999; 67: 63038.
  • 46
    Shibata K, Hasebe A, Into T, Yamada M, Watanabe T. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J Immunol 2000; 165: 653844.
  • 47
    Cole BC, Washburn LR. Mycoplasma arthritidis pathogenicity. membranes, MAM, and MAV1. In: RazinS, HerrmannR, eds. Molecular Biology and Pathogenicity of Mycoplasmas. New York: Kluwer Academic/Plenum Publishers, 2002:47389.
  • 48
    Muhlradt PF. Immunomodulation by mycoplasmas: artifacts, facts and active molecules. In: RazinS, HerrmannR, eds. Molecular Biology and Pathogenicity of Mycoplasmas. New York: Kluwer Academic/Plenum Publishers, 2002:44572.
  • 49
    Wieslamder A, Boyer MJ, Wroblewski H. Membrane protein structure. In: ManiloffJ, McElhaneyRN, FinchLR, BasemanJB, eds. Mycoplasmas – Molecular Biology and Pathogenesis. Washington, DC: American Society for Microbiology, 1992: 93112.
  • 50
    Chambaud I, Wroblewski H, Blanchard A. Interactions between mycoplasma lipoproteins and the host immune system. Trends Microbiol 1999; 7: 4939.
  • 51
    Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun 1998; 66: 480410.
  • 52
    Jan G, Brenner C, Wroblewski H. Purification of Mycoplasma gallisepticum membrane proteins p52, p67 (pMGA), and p77 by high-performance liquid chromatography. Protein Expr Purif 1996; 7: 1606.
  • 53
    Fraser CM, Gocayne JD, White O et al. The minimal gene complement of Mycoplasma genitalium. Science 1995; 270: 397403.
  • 54
    Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 1996; 24: 442049.
  • 55
    Sasaki Y, Ishikawa J, Yamashita A et al. The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans. Nucleic Acids Res 2002; 30: 5293300.
  • 56
    Jan G, Fontenelle C, Verrier F, Le Henaff M, Wroblewski H. Selective acylation of plasma membrane proteins of Mycoplasma mycoides subsp. mycoides SC, the contagious bovine pleuropneumonia agent. Curr Microbiol 1996; 32: 3842.
  • 57
    Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 2002; 32: 333747.
  • 58
    Toujima S, Kuwano K, Zhang Y et al. Binding of glycoglycerolipid derived from membranes of Acholeplasma laidlawii PG8 and synthetic analogues to lymphoid cells. Microbiology 2000; 146: 231723.
  • 59
    Shimizu T, Arai S, Imai H, Oishi T, Hirama M, Koito A, Kida Y, Kuwano K. Glycoglycerolipid from the membranes of Acholeplasma laidlawii binds to human immunodeficiency virus-1 (HIV-1) and accelerates its entry into cells. Curr Microbiol 2004; 48: 1828.
  • 60
    Yogev D, Browning GF, Wise KS. Genetic mechanisms of surface variation. In: RazinS, HerrmannR, eds. Molecular Biology and Pathogenicity of Mycoplasma. New York: Plenum Publishers, 2002: 41744.
  • 61
    Arai S, Furukawa M, Munakata T, Kuwano K, Inoue H, Miyazaki T. Enhancement of cytotoxicity of active macrophages by mycoplasma: role of mycoplasma-associated induction of tumor necrosis factor-alpha (TNF-alpha) in macrophages. Microbiol Immunol 1990; 34: 23143.
  • 62
    Sugama K, Kuwano K, Furukawa M, Himeno Y, Satoh T, Arai S. Mycoplasmas induce transcription and production of tumor necrosis factor in a monocytic cell line, THP-1, by a protein kinase C-independent pathway. Infect Immun 1990; 58: 35647.
  • 63
    Nishimoto M, Akashi A, Kuwano K, Tseng CC, Ohizumi K, Arai S. Gene expression of tumor necrosis factor alpha and interferon gamma in the lungs of Mycoplasma pulmonis-infected mice. Microbiol Immunol 1994; 38: 34552.
  • 64
    Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86: 59748.